- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-risk Myelodysplastic Syndromes With Excess Blasts in Brazil
Total 1 results
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland